# Cullinan Therapeutics, Inc.: Form 8-K, filed Aug 10, 2023

- Company: [Cullinan Therapeutics, Inc.](/companies/cgem.md) (CIK 1789972)
- Form: 8-K
- Filed: 2023-08-10
- Accepted by EDGAR: Aug 10, 2023, 07:07 ET
- Period: 2023-08-10
- Accession: 0000950170-23-040950
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1789972/000095017023040950/cgem-20230810.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1789972/000095017023040950/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1789972/000095017023040950/cgem-20230810.htm

Filed Aug 10, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-040950. Last ingested by Listed: Nov 10, 2026, 16:50 ET. No prices; not investment advice.